Clinical Research Process is Explained in Miami-focused Webinar December 8th

Local Partners, Nonprofit Advocates & International Organizations Share Information on Clinical Research

Miami, FL, November 23, 2020— The AWARE for All – Miami webinar is an important program that builds awareness about both clinical research participation and the critical role that individuals who participate in clinical trials play in advancing new medicines and treatments.

The Center for Information and Study on Clinical Research Participation (CISCRP) invites the Miami community to attend AWARE for All, a free webinar about clinical trials on Tuesday, December 8th, from 4-6pm EDT via a customized, secure online platform.

For the vast majority of individuals, the idea of clinical trials is a new and unfamiliar one. Most people first learn about clinical trials at the same time they are diagnosed with a serious illness for which no medication is available or adequate. Patients, their families, friends and health care providers must gather information quickly to make decisions about whether to participate. This rush to navigate the unfamiliar terrain of clinical trials is often overwhelming and confusing.

CISCRP’s AWARE for All – Miami program comes at a critically important time. Public interest in learning about clinical trials is high and the need for study volunteers in all disease conditions—including COVID-19 clinical trials—has increased significantly. The free program aims to offer an introduction and insight into the clinical research process, the decision to participate, and even the research team and their roles. Led by CISCRP, a non-profit, and supported by local research organizations, advocacy groups and a consortium of biopharmaceutical and service provider companies, the educational program is open to all members of the public.

Clinical research participant Jim Butler thanks his wife who brought the clinical trial opportunity to his attention and feels it was “an important way to be proactive about his diagnosis.” Jim referred to his research participation as something that he “feels really good about doing and is glad he can contribute to…”

Tomma Hargraves is a clinical trial participant and credits her participation with surviving Stage 3 lung cancer 14 years ago. Since then, she has participated in other clinical trials and serves as a patient liaison helping others navigate clinical trials.

Dr. Rishi Kakar, Chief Scientific Officer & Associate Medical Director, Segal Trials will be the overview speaker. In addition to a facilitated conversation with patients, researchers and health care professionals, there will also be two – 5-minute health exercises and a virtual health fair with over 30 local and national community health organizations.

“This unique online program will answer a lot of key questions about the clinical research process, how clinical trials work, and what to expect as a study participant´ said Joan Chambers, Senior Director at CISCRP.  “Viewers will learn about clinical trials, straight from the patients and researchers who take part in them with a facilitated conversation and be able to submit questions via a chatbox during the program. We’re extremely excited to be presenting this event with support from a diverse team of stakeholders from the Miami community.”

AWARE for All – Miami Clinical Research Webinar will be held Tuesday, December 8th, from 4-6pm EDT.  Attendance is free, but please register today by clicking here. To learn more, visit awareforall.org or call 877-633-4376.

The AWARE for All – Miami supporters include Allergy & Asthma Network, American Kidney Foundation, Arianna’s Center, Bladder Cancer Advocacy Network, Clinical Pharmacology of Miami, Clinical Site Partners, LLC, Debbie’s Dream, Florida Breast Cancer Foundation, JDRF, Latino’s Salud, Lupus Research Alliance, Myovant, NAMI, National Kidney Foundation, National MS Society, Pals for Health, Peoples Science, Segal Trials, Susan G. Komen,  and the AWARE Industry Consortium.

About CISCRP

The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit www.CISCRP.org for more information or to participate in CISCRP’s educational initiatives. For additional questions about AWARE for All, contact awareforall@ciscrp.org or call 877-633-4376.

 

 

###

CISCRP’s Patient Diversity Media Campaign Cited in ISMPP Article

PDMC-broadsheet-English-Spanish
The campaign is in English and Spanish.

CISCRP’s educational Patient Diversity Media Campaign was recently cited in an article in The MAP Newsletter, titled “Equity, Diversity, and Inclusion: Defining a Roadmap for Our Profession”.

Authored by Catherine Skobe, MPH, Pfizer, Angela Sykes, MA, MPhil, Pfizer, and Chris Winchester, DPhil, Oxford PharmaGenesis, the article discusses the importance of improving the outcomes for diverse populations in healthcare, building trust with patient and caregiver audiences, communicating scientific research clearly and making information accessible to all. Pfizer and Oxford Phamagenesis were among a number of companies that recently supported CISCRP’s Patient Diversity Media Campaign.

The MAP is a publication of ISMPP (International Society for Medical Publication Professionals).

CISCRP Webinar About Clinical Trials Set for November 18th Featuring the Los Angeles Community

CISCRP (Center for Information and Study on Clinical Research Participation), a non-profit, announces it's AWARE for All webinar about clinical trials and clinical research participation. This free event has a Los Angeles focus, with patients and researchers from the area participating in a moderated panel. There is also a virtual health fair.

Los Angeles, CA — November 5th — CISCRP (Center for Information and Study on Clinical Research Participation) invites the Los Angeles Community to attend AWARE for All, a free webinar about clinical trials on Wednesday, November 18th, from 4-6PM PDT, via a customized, secure online platform.

CISCRP’s AWARE for All – Los Angeles program comes at a critically important time. Public interest in learning about clinical trials is high and the need for study volunteers in all disease conditions—including COVID-19 clinical trials—has increased significantly. The free program aims to inform and empower the public in understanding the clinical research process in order to make decisions about their health care. Led by CISCRP, a non-profit, and supported by local research organizations, advocacy groups and a consortium of biopharmaceutical and service provider companies, the educational program is open to all members of the public.

“We’re excited to be presenting this event,” said Joan Chambers, Senior Director at CISCRP. “The online program will answer a lot of key questions about the clinical research process, how clinical trials work, and what to expect as a study participant. Viewers will learn about clinical trials, straight from the patients and researchers who take part in them with a facilitated conversation and be able to submit questions via a chatbox during the program.”

Dr. Jonathan Jackson from Massachusetts General Hospital and the Harvard Medical School will be the overview speaker. In addition to the panel discussion, there will also be two – 5-minute health exercises and a virtual health fair with local and national community health advocates and researchers..

“Clinical research awareness is vital to the success of clinical trials,” added Dr. Jonathan Jackson, Ph.D., Director of Community Access, Recruitment, and Engagement (CARE) Research Center. “The success of clinical trials also depends on including a diverse and inclusive group of individuals representative of those who may receive the new therapy if it is approved for use.”

Paulette McDaniels is a clinical research participant and encourages others to learn as much as they can about a clinical trial before they decide to join. She also says you learn more about your own health and body in a clinical study, and that can help inform the study team. “It’s a team effort. If you aren’t working with your doctors and the team that’s doing the study, nobody is going to get anywhere,” says McDaniels.

Clinical research participant Jim Butler thanks his wife who brought the clinical trial opportunity to his attention and feels it was “an important way to be proactive about his diagnosis.” Jim referred to his research participation as something that he “feels really good about doing and is glad he can contribute to…”

AWARE for All – Los Angeles Clinical Research Webinar will be held Wednesday, November 18th, from 4-6pm PDT. Attendance is free, but please register today by clicking here. To learn more, visit awareforall.org or call 877-633-4376.

The AWARE for All – Los Angeles supporters include Allergy & Asthma Network, City of Hope, Pancreatic Cancer Action Network, PALS for Health, Alzheimer’s LA, Debbie’s Dream Foundation, Alliance for a Better Community, Being Alive LA, WeSPARK Cancer Support Center, Providence Clinical Research, Peer Plus, and the AWARE Industry Consortium.

About CISCRP
The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit http://www.CISCRP.org for more information or to participate in CISCRP’s educational initiatives. For additional questions about AWARE for All, contact awareforall@ciscrp.org or call 877-633-4376.

Clinical Trials Explained, Research Participants Honored

AWARE for All Event Shares How COVID-19 Pandemic is Affecting Clinical Research

RALEIGH, N.C. (OCTOBER 5, 2020) — The Center for Information and Study on Clinical Research Participation (CISCRP) hosted its AWARE for All – Raleigh virtual community event on October 22. Hundreds of individuals attended to ask questions and to learn about the clinical research process and the role it plays in developing new treatments, vaccines, and devices. This free online event brought clinical research education directly to patients and the public and featured North Carolina-based study participants, research professionals, advocates, and industry stakeholders.

The AWARE for All – Raleigh event featured an overview presentation followed by a facilitated lively conversation with patients and health professionals, virtual health exercises—a Shibashi movement exercise and a lung cancer risk assessment; and a virtual health fair with exhibits from local Raleigh-area health and wellness organizations. The event was organized by the Center for Information and Study on Clinical Research Participation (CISCRP), a leading non-profit dedicated to educating the general public and patient communities about clinical participation. It was the organization’s third virtual event since the start of the global health pandemic in March.

Stefanie Belanger, Assistant Director of Clinical Research Operations at the Clinical Protocol Office of the UNC Lineberger Comprehensive Cancer Center presented an overview of clinical research. Clinical trials are carefully designed research studies in human volunteers to answer specific health questions. They are the fastest and safest way to find treatments that work in people and ways to improve public health.  Often a clinical trial is used to learn if a new treatment is more effective and/or has less harmful side effects than the standard treatment.

The event featured a facilitated conversation with study volunteer Tomma Hargraves; Pablo Graiver, Vice President of Patient Engagement, IQVIA; Dr. Brian Rothman, Associate Director at Otsuka Pharmaceutical Companies; Mary Hart, Director of Research, Allergy & Asthma Network; and Dr. Purvi Parikh, Medical Director of Allergy & Asthma Associates of Murray Hill. CISCRP Founder and Board Chair Ken Getz moderated the discussion. Attendees asked a variety of questions to the patients and health care professionals to answer, making the discussion more interactive, lively and informative.

Hargraves credits her participation in a clinical trial with surviving Stage 3 lung cancer 14 years ago. Since then, she has participated in other clinical trials and serves as a patient liaison helping others navigate clinical trials.

The COVID-19 pandemic has impacted clinical trials positively in general, the panel agreed. They are generally continuing under new safety protocols to minimize contact and maintain patient and physician safety including in-home, virtual visits and telemedicine appointments.

“Remote visits, online diaries and medication delivery make it easier for patients to stay safe and continue to participate,” said Parikh. “It has become more convenient for people from rural communities to participate.”

Rothman said increased patient participation and access to clinical trials is critical. “We need data that is representative of the entire population,” he said. “The success of clinical trials also depends on including a diverse and inclusive group of people representative of those who may receive the new therapy if it is approved for use.”

As part of this online educational clinical research program, attendees had the opportunity to visit over 20 local health and wellness organizations in the virtual health fair and access educational materials and read Medical Hero articles – https://www.ciscrp.org/events/aware-raleigh-virtual-health-fair/  Organizations include Duke Health, Hemophilia of NC, Parkinson’s Association of the Carolinas, LGBT Center of Raleigh, Ronald McDonald House of Chapel Hill, and many more. The Raleigh virtual health fair remains open.

CISCRP is a non-profit organization dedicated to educating the general population and patient communities about clinical participation. They work with local advocates around the country to plan and host educational events about the clinical research process. Contact CISCRP at 1-877-MED-HERO or www.ciscrp.org to learn more about CISCRP’s mission, ‘education before participation.’

CISCRP recently launched informational videos about the different phases of clinical research participation and highlights why it takes so long to develop new therapies. The first video of the series can be viewed here: https://www.youtube.com/watch?v=iid3BMqopMM.  Additional clinical research videos are also available to watch.

The AWARE for All – Raleigh supporters include Allergy & Asthma Network, Brain Injury Association of North Carolina, Debbie’s Dream Foundation, Duke – Office of Clinical Research, Hemophilia of North Carolina, Javara, LGBT Center of Raleigh, Lung Cancer Initiative, Lupus Research Alliance, Parkinson Association of the Carolinas, PRA Health Sciences – Rare Disease Center, Ronald McDonald House of Chapel Hill and the AWARE Industry Consortium.

About CISCRP

The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical

research process. Visit www.CISCRP.org for more information or to participate in CISCRP’s educational initiatives. For additional questions about AWARE for All, contact awareforall@ciscrp.org or call 877-633-4376.